Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 16;36(32):e208.
doi: 10.3346/jkms.2021.36.e208.

Patient Perspectives and Preferences Regarding Gout and Gout Management: Impact on Adherence

Min Kyung Chung  1 , Sung Soo Kim  2 , Yun Hong Cheon  3 , Seung Jae Hong  4 , Hyo Jin Choi  5 , Mi Ryoung Seo  5 , Jiwon Hwang  6 , Joong Kyong Ahn  7 , Sang Heon Lee  8 , Hong Ki Min  8 , Hoon Suk Cha  9 , Shin Seok Lee  10 , Jennifer Lee  11 , Ki Won Moon  12 , Chang Keun Lee  13 , Hyun Ok Kim  14 , Young Sun Suh  14 , Seung Cheol Shim  15 , Seong Wook Kang  15 , Jinhyun Kim  15 , Sang Tae Choi  16 , Jung Soo Song  17 , Jisoo Lee  18 ; Korean Society of Gout Research
Affiliations

Patient Perspectives and Preferences Regarding Gout and Gout Management: Impact on Adherence

Min Kyung Chung et al. J Korean Med Sci. .

Abstract

Background: Patient-centered management is becoming increasingly important in gout, but there are limited studies exploring patients' perspectives and preferences. We aimed to investigate patients' perspectives and preferences regarding gout and gout management, and their impacts on adherence to urate lowering therapy (ULT).

Methods: A paper-based survey was performed in patients with gout seen at the rheumatology outpatient clinics of 16 tertiary hospitals. The survey included questions regarding demographics, comorbidities, gout attacks, current treatment and adherence, and patients' perspectives and preferences regarding gout and gout management. Multivariate regression analysis was performed to determine the factors associated with ULT adherence.

Results: Of 809 surveyed patients with gout, 755 (94.5%) were using ULT. Among those using ULT, 89.1% had ≥ 80% adherence to ULT. Majority of the patients knew management strategies to some extent (94.8%), perceived gout as a life-long disease (91.2%), and were making efforts toward practicing at least one lifestyle modification (89.2%). Most patients (71.9%) obtained information about gout management during their clinic visits. Approximately half of the patients (53.6%) preferred managing their disease with both ULT and lifestyle modification, 28.4% preferred ULT only, and 17.4% preferred lifestyle modification only. Adherence was better in patients with older age (odds ratio [OR], 1.03), those with better knowledge of gout management strategies (OR, 3.56), and those who had preference for ULT (OR, 2.07).

Conclusion: Patients' perspectives and management preferences had high impacts on adherence to ULT in gout. Consideration of patients' perspectives and preferences is important for achieving the desired clinical outcome in gout.

Keywords: Disease Management; Gout; Patient Preference; Perspective.

PubMed Disclaimer

Conflict of interest statement

The authors have no potential conflicts of interest to disclose.

References

    1. Chen-Xu M, Yokose C, Rai SK, Pillinger MH, Choi HK. Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the National Health and Nutrition Examination Survey, 2007–2016. Arthritis Rheumatol. 2019;71(6):991–999. - PMC - PubMed
    1. Mattiuzzi C, Lippi G. Recent updates on worldwide gout epidemiology. Clin Rheumatol. 2020;39(4):1061–1063. - PubMed
    1. Park JS, Kang M, Song JS, Lim HS, Lee CH. Trends of gout prevalence in South Korea based on medical utilization: a National Health Insurance Service Database (2002–2015) J Rheum Dis. 2020;27(3):174–181.
    1. Dalbeth N, Choi HK, Joosten LA, Khanna PP, Matsuo H, Perez-Ruiz F, et al. Gout. Nat Rev Dis Primers. 2019;5(1):69. - PubMed
    1. Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castañeda-Sanabria J, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017;76(1):29–42. - PubMed

Substances